Development and assessment individual maximum permissible dose method of I-131 therapy in high risk patients with differentiated papillary thyroid cancer. > Paper

Skip to content

Publications

Sub Visual

Paper

2003 Development and assessment individual maximum permissible dose method …

Post author info

profile_image
  • Author
  • Date 17-12-19 07:17
  • Views 0
  • Comments 0

Post content

Basic info

Basic info
Paper Development and assessment individual maximum permissible dose method of I-131 therapy in high risk patients with differentiated papillary thyroid cancer.
Journal Korean J Nucl Med
Author Kim JC, Yoon JH, Bom HS, Jaegal YJ, Song HC, Min JJ, Jeong HJ, Kim SM, Heo YJ, Li MH, Park YK, Chung JK.
Volume, Page 37(2):110-119.
Development and assessment individual maximum permissible dose method of I-131 therapy in high risk patients with differentiated papillary thyroid cancer.